Skip to main content

Table 1 Association between several medical conditions and visfatin

From: Visfatin, glucose metabolism and vascular disease: a review of evidence

Medical Condition Visfatin
Atherosclerosis Increased serum levels [10, 31]
Increased expression in instable plaques [31]
Endothelial dysfunction Increased serum levels [18]
Cardioprotection Reduces infarct area [36]
Metabolic Syndrome Controversial, Increased serum levels [34]
Adiponectin Controversial [18, 27]
Hepatic Fat Disease Diminished serum levels in steatohepatitis [16]
Increased serum levels with progressive portal inflammation [17]
Tumoral replication Visfatin antagonist being tested [19]
Acute lung injury Increased serum levels [15]
Renal insufficiency Increased serum levels [18]
Beta cell function impairment Increased serum levels [10, 22, 23, 28, 29]
Insulin resistance No correlation [20, 22, 23]
Insulin-mimetic effect Controversial, no effect [5, 10, 1520, 2224, 2729]
Diabetes Controversial [18, 23, 27, 28]
Obesity Increased serum levels [20, 22]
Visceral Fat Controversial, no correlation [5, 1520, 27]
Vascular smooth muscle Promotes inflammation [32]